In a news release, drug manufacturER
NextWave Pharmaceuticals announced FDA approval of
its drug Qullivant XR (<span style = 'background-color: #dae8f4'>Methylphenidate</span>
hydrochloride), the first once-daily, oral-suspension medication for the treatment of
According to the company, the central nER
vous system stimulant is the first extended-release, once-daily liquid ADHD medication on the market. It helps control ADHD symptoms within 45 minutes of
administration and lasts for 12 hours.